C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2006
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/12/2006	US7148377 4-Alkoxy cyclohexane-1-amino-carboxylic acid esters and method for the production thereof
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006	US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7147937 Organic element for electroluminescent devices
12/07/2006	WO2006129164A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
12/07/2006	US20060276526 Crystalline Form of Telmisartan Sodium
12/07/2006	US20060276523 Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
12/07/2006	US20060276467 Sodium channel modulators
12/06/2006	EP1505066B1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
12/06/2006	CN1874768A N3 alkylated benzimidazole derivatives as MEK inhibitors
12/06/2006	CN1288147C Stable polymorph of FLIBANSERIN, technical process for its preparation and the use thereof for preparing medicaments
12/05/2006	US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
12/05/2006	US7144893 4-aryl quinols and analogs thereof as therapeutic agents
11/2006
11/30/2006	US20060270693 Ether derivative
11/30/2006	US20060270651 Antibacterial agents
11/29/2006	EP1725632A1 New materials for injecting or transporting holes and organic electroluminescence devices using the same
11/29/2006	EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	CN1871222A Ccr3受体拮抗剂 Ccr3 receptor antagonists
11/29/2006	CN1286836C Novel diketopyrrolopyrrole pigments
11/29/2006	CN1286820C 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
11/28/2006	US7141676 that bind target proteins, such as monoclonal antibodies, for in vitro bioassays, or for in vivo diagnosis or therapy
11/28/2006	US7141600 Small molecule inhibition of a PDZ-domain interaction
11/28/2006	US7141598 Imidazole derivatives, production method thereof and use thereof
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141352 Basic compound, resist composition and patterning process
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2378007C Benzimidazole compounds
11/28/2006	CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/23/2006	WO2006124780A2 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
11/23/2006	WO2006124118A1 Diarylhydantoin compounds
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	CA2608436A1 Diarylhydantoin compounds and their use in the treatment of hyperproliferative disorders
11/22/2006	EP1724258A1 Heteroarylphenylurea derivative
11/22/2006	EP1723139A1 Cell targeting conjugates
11/22/2006	EP1722863A1 Microcapsules with uv filter activity and process for producing them
11/22/2006	EP1722793A1 Bicyclic modulators of androgen receptor function
11/22/2006	EP1461034B1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1277752B1 Process for producing optically active sulfoxide derivative
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1285595C Preparation process of thione
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138414 Antidiabetic agents
11/21/2006	CA2272285C Amide derivatives and medicinal compositions thereof
11/16/2006	WO2006119713A2 Antineoplastic compounds and pharmaceutical compositions thereof
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	WO2006076415A3 Exo- and diastereo- selective syntheses of himbacine analogs
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/16/2006	US20060257613 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/16/2006	CA2607298A1 Antineoplastic compounds and pharmaceutical compositions thereof
11/16/2006	CA2602853A1 Ring closing and related methods and intermediates
11/15/2006	EP1720845A1 Isothiourea derivatives
11/15/2006	EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1007514B1 Heterocyclic ketones as npy y5 antagonists
11/15/2006	CN1863788A Substances of antimicrobial, antifungoid and antiprotozoan activities
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/09/2006	WO2006118534A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux
11/09/2006	WO2006067215A3 Intermediate compounds for the preparation of angiotensin ii receptor antagonists
11/09/2006	US20060252941 Reacting ketopinic acid with p-toluenesulfonhydrazide under nitrogen atmosphere
11/09/2006	US20060252793 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
11/09/2006	US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
11/08/2006	EP1719766A2 A process for the preparation of telmisartan
11/08/2006	EP1719765A1 Novel sulfone amide derivative
11/08/2006	EP1719761A1 Novel heterocyclic compound
11/08/2006	EP1718637A2 Benzimidazolyl derivatives as kinase inhibitors
11/08/2006	EP1718342A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
11/08/2006	CN1860121A Substituted imidazopyrimidines for the prevention and treatment of cancer
11/08/2006	CN1860117A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/08/2006	CN1860103A Benzimidazole derivates: preparation and pharmaceutical applications
11/08/2006	CN1859907A Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132440 such as 2-[4-(2-Phenyl-[1,3]dioxolan-2-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; for treatment of cancer
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain
11/03/2006	CA2545595A1 A process for the preparation of telmisartan
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2005028624A3 Molecular scaffolds for kinase ligand development
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716127A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/02/2006	EP1716100A2 Therapeutic amide derivatives
11/02/2006	EP1244446B1 Thrombopoietin mimetics
11/02/2006	EP1143959B1 Antifungal activity of dicationic molecules
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex

1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 154